Progyny, Inc. (PGNY)
Thursday, November 5, 2026
Key stats
Chart
Price, buy and sell signals and key levels on one chart.
Thursday, November 5, 2026
Price, buy and sell signals and key levels on one chart.
Progyny (PGNY) closed at $30.10 on Nov 4, 2026, up 3.6% on the day. The stock is up 16.2% over the past month, down 0.4% over three months, up 17.2% year to date and up 62.1% over the past year (since Nov 4, 2025). It trades 9.0% below its 52-week high of $33.06 and 87.0% above its 52-week low of $16.10. The close sits above its 50-day moving average ($27.11) and above its 200-day moving average ($24.43).
Over its last 8 reports the stock moved an average of 13.3% on the first trading day after earnings, beating the options-implied move in 4 of 8.
PGNY options were pricing 65% at-the-money implied volatility on Nov 2, 2026, an IV rank of 67 over the past year.
Over the last 8 reports, PGNY moved an average of 13.3% on the first trading day after earnings. The move beat the options-implied move in 4 of 8 reports.
Yes — the Nov 4, 2026 close of $30.10 is 23.2% above the 200-day average of $24.43.
PGNY closed 9.0% below its 52-week high of $33.06.
Progyny, Inc., a benefits management company, provides fertility, family building, and women's health benefits solutions in the United States. It offers fertility benefits solutions, such as differentiated benefits plan design that includes smart cycle treatment bundle; personalized concierge-style member support services; and a selective network of fertility specialists. The company also offers Progyny Rx, an integrated pharmacy benefits solution that provides access to the medications needed during their treatment and offers care management services, as well as pregnancy and postpartum, menopause and midlife, benefit and leave navigation, and parent and child wellbeing solutions. In addition, it provides assistance service program where various services can be offered through a reimbursement program, including adoption, surrogacy, doula, and travel reimbursement when travel is required to receive medical services. The company was formerly known as Auxogyn, Inc. and changed its name to Progyny, Inc. in 2015. Progyny, Inc. was incorporated in 2008 and is headquartered in New York, New York.